Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

157
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
157
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

123
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
123
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

210
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
210
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

270
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
270

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing.

Human genomics·2015
Same author

Prevalence of autoimmune disease in moyamoya disease patients in Western Chinese population.

Journal of the neurological sciences·2015
Same author

Angiotensin II and its receptor in activated microglia enhanced neuronal loss and cognitive impairment following pilocarpine-induced status epilepticus.

Molecular and cellular neurosciences·2015
Same author

Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages.

Nucleic acids research·2015
Same author

IAOseq: inferring abundance of overlapping genes using RNA-seq data.

BMC bioinformatics·2015
Same author

Inverse association between intelligence quotient and urinary retinol binding protein in Chinese school-age children with low blood lead levels: results from a cross-sectional investigation.

Chemosphere·2015
Same journal

MCT1 inhibition reprograms Treg metabolism via ABC transporters: implications for tumor immunity and the prognosis of acute myeloid leukemia patients.

European journal of medical research·2026
Same journal

Delayed bedtime on workdays is associated with an increased prevalence of gallstones: a population-based study.

European journal of medical research·2026
Same journal

Salvianolic acid B attenuates post-cardiac arrest cerebral ischemia-reperfusion injury via activation of the Nrf2 signaling pathway.

European journal of medical research·2026
Same journal

Clinical value of sputum galactomannan testing in the diagnosis of invasive pulmonary aspergillosis among chronic obstructive pulmonary disease patients.

European journal of medical research·2026
Same journal

Integrative analysis reveals luteolin's molecular targets and mechanisms in pancreatic cancer treatment.

European journal of medical research·2026
Same journal

Non-linear association between cardiometabolic index and helicobacter pylori infection: a cross-sectional study.

European journal of medical research·2026
See all related articles

Related Experiment Video

Updated: May 15, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.7K

Host-directed therapy for tuberculosis.

Na Tian1, Hongqian Chu2, Qi Li1

  • 1Department of Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, China.

European Journal of Medical Research
|April 11, 2025
PubMed
Summary
This summary is machine-generated.

Host-directed therapy (HDT) offers a novel strategy to combat tuberculosis (TB) by enhancing the host immune response. This approach repurposes existing drugs to improve TB treatment efficacy and reduce resistance.

Keywords:
Mycobacterium tuberculosisHost responseHost-directed therapyInfectious diseasesTuberculosis

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.5K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K

Related Experiment Videos

Last Updated: May 15, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.7K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.5K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pharmacology

Background:

  • Current tuberculosis (TB) treatments face challenges including drug resistance, adverse effects, and lengthy durations.
  • There is a critical need for improved therapeutic strategies, termed 'me-better' regimens, to overcome these limitations.

Purpose of the Study:

  • To review host-directed therapy (HDT) as a promising approach for TB treatment.
  • To explore the potential of repurposing existing drugs for HDT in TB.
  • To discuss the mechanisms and future directions of HDT in combating drug-resistant TB.

Main Methods:

  • Review of current literature on host-directed therapy for tuberculosis.
  • Analysis of drug repurposing strategies for TB treatment.
  • Exploration of immunological mechanisms targeted by HDT, including autophagy and inflammation modulation.

Main Results:

  • HDT enhances the host immune response to Mycobacterium tuberculosis, promoting mechanisms like autophagy and antimicrobial peptide production.
  • Repurposed drugs used in HDT can minimize drug resistance, reduce treatment duration, and mitigate adverse effects.
  • HDT shows promise in addressing challenges posed by multidrug-resistant and extensively drug-resistant TB strains.

Conclusions:

  • Host-directed therapy represents a significant advancement in TB treatment, offering a complementary strategy to conventional anti-TB drugs.
  • Further research into HDT candidates and their mechanisms is crucial for optimizing TB treatment outcomes.
  • HDT holds potential to revolutionize the management of tuberculosis, particularly in the face of rising drug resistance.